Leukemia cell microvesicles promote survival in umbilical cord blood hematopoietic stem cells

EXCLI Journal

Volumn 14, Issue , 2015, Pages 423-429

  Razmkhah, Farnaz ^a   Soleimani, Masoud ^a   Mehrabani, Davood ^b   Karimi, Mohammad Hossein ^c   Kafi Abad, Sedigheh Amini ^d  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d HIGH INSTITUTE FOR RESEARCH AND EDUCATION IN TRANSFUSION MEDICINE   (Iran)

Author keywords

Cell survival; Hematopoietic stem cells; Leukemia; Microvesicles; P53 gene expression

Indexed keywords

CD34 ANTIGEN; CD45 ANTIGEN;

APOPTOSIS; ARTICLE; CELL COUNT; CELL SURVIVAL; CELL VACUOLE; CELL VIABILITY; CONTROLLED STUDY; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; JURKAT CELL LINE; LEUKEMIA CELL; MICROVESICLE; TUMOR SUPPRESSOR GENE; UMBILICAL CORD BLOOD;

EID: 84924857413     PISSN: None     EISSN: 16112156     Source Type: Journal    
DOI: 10.17179/excli2015-101     Document Type: Article

References (30)

1. Al-Nedawi K, Meehan B, Micallef J, Lhotak V, May L, Guha A, et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol. 2008;10:619-24.
2. Andreola G, Rivoltini L, Castelli C, Huber V, Perego P, Deho P, et al. Induction of lymphocyte apoptosis by tumor cell creation of FasL-bearing microvesicles. J Exp Med. 2002;195:1303–16.
3. Baj-Krzyworzeka M, Szatanek R, Weglarczyk K, Baran J, Urbanowicz B, Branski P, et al. Tumourderived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes. Cancer Immunol Immunother. 2006;55:808–18.
4. Benchimol S. p53-dependent pathways of apoptosis. Cell Death Diff. 2001;8:1049-51.
5. Boing AN, Hau CM, Sturk A, Nieuwland R. Platelet microparticles contain active caspase 3. Platelets. 2008;19:96-103.
6. Camussi G, Deregibus MC, Bruno S, Cantaluppi V, Biancone L. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int. 2010;78:838-48.
7. Chalmin F, Ladoire S, Mignot G, Vincent J, Bruchard M, Remy-Martin JP, et al. Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immune suppressive function of mouse and human myeloid-derived suppressor cells. J Clin Inves. 2010;120:457–71.
8. Distler JH, Pisetsky DS, Huber LC, Kalden JR, Gay S, Distler O. Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases. Arthritis Rheum. 2005;52:3337-48.
9. Doormal FFV, Kleinjan A, Nisio MD, Buller HR, Nieuwland R. Cell-derived microvesicles and cancer. Netherlands J Med. 2009;67:266-73.
10. Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med. 2008;359:938-49.
11. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, et al. Serum microRNAs are promising novel biomarkers. PLoS ONE. 2008;3:e3148.
12. Hakulinen J, Junnikkala S, Sorsa T, Meri S. Complement inhibitor membrane cofactor protein (MCP; CD46) is constitutively shed from cancer cell membranes in vesicles and converted by a metalloproteinase to a functionally active soluble form. Eur J Immunol. 2004;34:2620-9.
13. Huber V, Fais S, Iero M, Lugini L, Canese P, Squarcina P, et al. Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape. Gastroenterology. 2005;128:1796–804.
14. Hussein MN, Boing AN, Sturk A, Hau CM, Nieuwland R. Inhibition of microparticle release triggers endothelial cell apoptosis and detachment. Thromb Haemost. 2007;98:1096-107.
15. Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication. J Proteom. 2010;73:1907-20.
16. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA. 2008;105:10513-8.
17. Nolte-'t Hoen EN, Buschow SI, Anderton SM, Stoorvogel W, Wauben MH. Activated T cells recruit exosomes secreted by dendritic cells via LFA-1. Blood. 2009;113:1977–81.
18. Piacibello W, Sanavio F, Garetto L, Severino A, Bergandi D, Ferrario J. Extensive amplification and selfrenewal of human primitive hematopoietic stem cells from cord blood. Blood. 1997;89:2644-53.
19. Putz U, Howitt J, Doan A, Goh C-P, Low L-H, Silke J, et al. The tumor suppressor PTEN is exported in exosomes and has phosphatase activity in recipient cells. Sci Signal. 2012;5:70.
20. Ratajczak J, Miekus K, Kusia M, Zhang J, Reca R, Dvorak P, et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia. 2006;20:847-56.
21. Rauch U, Antoniak S. Tissue factor-positive microparticles in blood associated with coagulopathy in cancer. Thromb Haemost. 2007;97:9-10.
22. Sapet C, Simoncini S, Loriod B, Puthier D, Sampol J, Nguyen C, et al. Thrombin-induced endothelial microparticle generation: identification of a novel pathway involving ROCK-II activation by caspase-2. Blood. 2006;108:1868-76.
23. Shedden K, Xie XT, Chandaroy P, Chang YT, Rosania GR. Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. Cancer Res. 2003;63:4331-7.
24. Skog J, Würdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008;10:1470-6.
25. Taylor DD, Gercel-Taylor C. Exosomes/microvesicles: mediators of cancer-associated immune suppressive microenvironments. Semin Immunopathol. 2011;33:441-54.
26. Tesselaar ME, Romijn FP, van der Linden IK, Prins FA, Bertina RM, Osanto S. Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost. 2007;5:520-7.
27. Valenti R, Huber V, Filipazzi P, Pilla L, Sovena G, Villa A, et al. Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes. Cancer Res. 2006;66: 9290-8.
28. Whitlow MB, Klein LM. Response of SCC-12F, a human squamous cell carcinoma cell line, to complement attack. J Invest Dermatol. 1997;109:39-45.
29. Zhang Y, Liu D, Chen X, Li J, Li L, Bian Z, et al. Secreted monocytic miR150 enhances targeted endothelial cell migration. Mol Cell. 2010;39:133–44.
30. Zhu U, You Y, Li Q, Zeng C, Fu F, Guo A, et al. BCR-ABL positive microvesicles transform normal hematopoietic transplants through genomic instability: implications for donor cell leukemia. Leukemia. 2014;28:1666-75.